Regard
NativeAI NativePrivateUpdated November 15, 2026The clinical decision support AI that is quietly reducing diagnostic errors in hospitals.
- Website
- regard.com
- Founded
- 2017
- CEO
- Eli Ben-Joseph
- HQ
- Los Angeles, CA, United States
- Stage
- Private
- Revenue
- Not disclosed
- Total Funding
- $84M
- Employees
- 201-500
Executive Summary
Updated Nov 12, 2026
What they do
- Reads the entire EHR chart to recommend diagnoses for inpatient clinicians
- Drafts proactive clinical notes before encounters, built around accurate diagnoses
- Supports CDI, screening and mid-revenue-cycle workflows from one clinical platform
Why it matters
- Catches missed diagnoses that busy clinicians skip because they lack time to read charts
- Captures documentation at the point of care, cutting retrospective CDI queries and denials
- Company reports more than $50M in earned revenue unlocked for health system partners
Best fit
- Large acute-care health systems seeking diagnostic accuracy and documentation integrity together
- CDI and revenue-cycle leaders tired of chasing charts after discharge
- Hospitals using Microsoft Dragon Copilot who want diagnostic insights added to ambient documentation
Watch-outs
- Revenue-capture positioning may draw payer and compliance scrutiny over coding intensity
- Coverage is mainly inpatient; specialty expansion to cardiology and surgery is recent
- Public funding record ends with a 2024 Series B, so check the runway
Products & Offerings
Regard Clinical Notes (Proactive Documentation)
Gives clinicians the relevant chart data before an encounter, combines it with patient-physician conversation, recommends diagnoses and drafts a comprehensive note within the EHR.
Regard Mid-Revenue Cycle / CDI
Captures complete diagnoses and clinical complexity at the point of care, supporting CDI review, utilization review, discharge planning and denial appeals.
Regard Screening
Reviews structured and unstructured data across all hospital patients to find people eligible for care interventions, along with quality gaps that keyword filters miss.
Regard for Microsoft Dragon Copilot
Integration that pairs Dragon Copilot's voice dictation and ambient listening with Regard's real-time diagnostic insights drawn from the full EHR.
Latest News
Fierce Healthcare · 25 days ago
PositiveUpdated Nov 12, 2026
Regard is a credible inpatient clinical AI vendor with real enterprise traction. Banner Health is rolling it out across all 33 of its acute-care hospitals, Cedars-Sinai is deploying it at two hospitals, and a Microsoft Dragon Copilot collaboration widens its reach. Health systems weighing AI for diagnosis capture and CDI should run a structured evaluation with clear metrics: diagnostic accuracy, how many suggestions physicians accept, fewer CDI queries, and audit-ready revenue impact. Compare it against EHR-native and CDI-incumbent alternatives before committing to a multi-year deal.
Signal Provenance
Latest observation date and source for each signal category
| Signal Category | Last Updated | Source |
|---|---|---|
Funding Signals Last funding round, Funding stage | Nov 10, 2026 | Cited web research |
Hiring Velocity Headcount, Headcount growth | Nov 15, 2026 | Research agents (estimate) |
Technical Output Research papers, GitHub activity | Nov 15, 2026 | Hugging Face Hub + news feed + research agents |
News Sentiment News mentions, News sentiment | Nov 15, 2026 | Verified news feed |
Partnership Signals Enterprise partnerships, Distribution partners | Nov 15, 2026 | Research agents (estimate) |
Revenue Indicators ARR estimate, Revenue growth | Nov 15, 2026 | Research agents (estimate) |
Leadership Signals CEO tenure, Founder-led | Oct 19, 2026 | Research agents (estimate) |
Competitive Position Category rank, Market share | Oct 18, 2026 | Research agents (estimate) |
Why this Bluescore?
6 dimensions, each scored 0–10 against all 250 companies. Each adds its weight × score to the Bluescore — see methodology
Regard's Bluescore of 31.6 rests most on Customer Adoption (5.2, 50th percentile). Its weakest area is Product Depth (1.5, 1st percentile).
In plain English
Regard's Bluescore of 31.6 out of 100 is held back mainly by Product Depth, which scored 1.5 of 10 and sits at the 1st percentile among the AI250, and by Talent & Research, which scored 2.1 of 10 and sits at the 4th percentile. Its strongest areas are Business Model & Revenue at 4.4 of 10 (45th percentile) and Customer Adoption at 5.2 of 10 (50th percentile), which added 9.2 and 6.8 points. Product Depth carries a 21% weight and still has 17.9 points left to gain, so improving it would move the Bluescore more than anything else, and the company currently ranks #248 of 247 overall, down 4 places since yesterday.
Written by AI from the scores below and checked against them; updated nightly.
Risks
Updated Nov 12, 2026